当前位置：
主页产品
详情

1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid methyl ester | CAS:1206979-63-6

1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid methyl ester

名称：1H-吡唑并[4,3-c]吡啶-6-羧酸甲酯 | 1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid methyl ester
CAS号：1206979-63-6
别名：
分子式：C₈H₇N₃O₂
分子量：177.16
EINESC号：

产品描述

物理化学性质

密度	1.403±0.06 g/cm3 (20 º

安全数据

没有数据	没有数据

SDS

来源	SDS样本
没有数据	没有数据

产品合成路线

名称	CAS号

文章

同行评议文献

Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate.Toni M Brand et al.Cancer biology & therapy, 11(3), 368-370 (2011-01-14) Lithium citrate for Canavan disease.Christopher G Janson et al.Pediatric neurology, 33(4), 235-243 (2005-10-01) Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography.S E Møller Journal of chromatography, 613(2), 223-230 (1993-04-02) Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.Assadi M, Janson C, Wang DJ, et al. European Journal of Pediatrics, 14, 354-359 (2010) Lithium citrate as treatment of Canavan disease.María Dolores Edo Solsona et al.Clinical neuropharmacology, 35(3), 150-151 (2012-05-18)

备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称	CAS号

产品描述

物理化学性质

安全数据

SDS

相关产品

相关资讯